Skip to main content
Top
Published in: World Journal of Surgery 3/2019

01-03-2019 | Original Scientific Report

Lung Adenocarcinoma has a Higher Risk of Lymph Node Metastasis than Squamous Cell Carcinoma: A Propensity Score-Matched Analysis

Authors: Han-Yu Deng, Miao Zeng, Gang Li, Guha Alai, Jun Luo, Lun-Xu Liu, Qinghua Zhou, Yi-Dan Lin

Published in: World Journal of Surgery | Issue 3/2019

Login to get access

Abstract

Background

Controversy still exists in which subtype of non-small-cell lung cancer [squamous cell carcinoma (SCC) or adenocarcinoma] is more likely to have lymph node (LN) metastasis. The aim of this study is to compare the pattern of LN metastasis in two cohorts of matched patients surgically treated for SCC or adenocarcinoma.

Methods

A retrospective analysis of patients undergoing lobectomy or segmentectomy with systematic lymphadenectomy without preoperative treatment for lung SCC or adenocarcinoma was conducted in this study. Data for analysis consisted of age, gender, tumor size, lobe-specific tumor location, tumor location (peripheral or central), and pathologic findings. We conducted the propensity score-matched (PSM) analysis to eliminate potential bias effects of possible confounding factors.

Results

From January 2015 to December 2016 in our department, we finally included a total of 387 patients (including 63 patients with SCC and 324 patients with adenocarcinoma) for analysis. For the unmatched cohort, there was no sufficient evidence of significantly different number of positive LNs (P = 0.90) and rate of LN metastasis (P = 0.23) between SCC patients and adenocarcinoma patients. However, potential confounding factors, for example gender, tumor size, tumor location, tumor differentiation, and total number of dissected LNs, were significantly different between patients with SCC and those with adenocarcinoma. In the analysis of matched cohort after PSM analysis, those above confounding factors were comparable between the two groups. However, patients with adenocarcinoma had significantly more mean positive LNs (2.2 and 0.7; P = 0.008) and a higher rate of LN metastasis (53% and 29%; P = 0.016) than those with SCC.

Conclusions

Lung adenocarcinoma had a higher risk of LN metastasis than SCC, suggesting that different therapeutic modalities may be indicated for the two different subtypes of lung cancer.
Literature
1.
go back to reference Herbst RS, Heymach JV, Lippman SM (2008) Lung cancer. N Engl J Med 359:1367–1380CrossRef Herbst RS, Heymach JV, Lippman SM (2008) Lung cancer. N Engl J Med 359:1367–1380CrossRef
2.
go back to reference Kawase A, Yoshida J, Ishii G et al (2012) Differences between squamous cell carcinoma and adenocarcinoma of the lung: are adenocarcinoma and squamous cell carcinoma prognostically equal? Jpn J Clin Oncol 42:189–195CrossRefPubMed Kawase A, Yoshida J, Ishii G et al (2012) Differences between squamous cell carcinoma and adenocarcinoma of the lung: are adenocarcinoma and squamous cell carcinoma prognostically equal? Jpn J Clin Oncol 42:189–195CrossRefPubMed
3.
go back to reference Asamura H, Chansky K, Crowley J et al (2015) The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer. J Thorac Oncol 10:1675–1684CrossRefPubMed Asamura H, Chansky K, Crowley J et al (2015) The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer. J Thorac Oncol 10:1675–1684CrossRefPubMed
4.
go back to reference Goldstraw P, Chansky K, Crowley J et al (2016) The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 11:39–51CrossRefPubMed Goldstraw P, Chansky K, Crowley J et al (2016) The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 11:39–51CrossRefPubMed
5.
go back to reference Oda M, Watanabe Y, Shimizu J et al (1998) Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: the role of systematic nodal dissection. Lung Cancer 22:23–30CrossRefPubMed Oda M, Watanabe Y, Shimizu J et al (1998) Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: the role of systematic nodal dissection. Lung Cancer 22:23–30CrossRefPubMed
6.
go back to reference Funakoshi Y, Maeda H, Takeda S et al (2010) Tumor histology affects the accuracy of clinical evaluative staging in primary lung cancer. Lung Cancer 70:195–199CrossRefPubMed Funakoshi Y, Maeda H, Takeda S et al (2010) Tumor histology affects the accuracy of clinical evaluative staging in primary lung cancer. Lung Cancer 70:195–199CrossRefPubMed
7.
go back to reference Saeteng S, Tantraworasin A, Euathrongchit J et al (2012) Nodal involvement pattern in resectable lung cancer according to tumor location. Cancer Manag Res 4(151–15):8 Saeteng S, Tantraworasin A, Euathrongchit J et al (2012) Nodal involvement pattern in resectable lung cancer according to tumor location. Cancer Manag Res 4(151–15):8
8.
go back to reference Zhang YK, Chai ZD, Tan LL et al (2017) Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer. World J Surg Oncol 15:64CrossRefPubMedPubMedCentral Zhang YK, Chai ZD, Tan LL et al (2017) Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer. World J Surg Oncol 15:64CrossRefPubMedPubMedCentral
9.
go back to reference Asamura H, Nakayama H, Kondo H et al (1996) Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: Are these carcinomas candidates for video-assisted lobectomy? J Thorac Cardiovasc Surg 111:1125–1134CrossRefPubMed Asamura H, Nakayama H, Kondo H et al (1996) Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: Are these carcinomas candidates for video-assisted lobectomy? J Thorac Cardiovasc Surg 111:1125–1134CrossRefPubMed
10.
go back to reference Takamochi K, Nagai K, Suzuki K et al (2000) Clinical predictors of N2 disease in non-small cell lung cancer. Chest 117:1577–1582CrossRefPubMed Takamochi K, Nagai K, Suzuki K et al (2000) Clinical predictors of N2 disease in non-small cell lung cancer. Chest 117:1577–1582CrossRefPubMed
11.
go back to reference Konaka C, Ikeda N, Hiyoshi T et al (1998) Peripheral non-small cell lung cancers 2.0 cm or less in diameter: proposed criteria for limited pulmonary resection based upon clinicopathological presentation. Lung Cancer 21:185–191CrossRefPubMed Konaka C, Ikeda N, Hiyoshi T et al (1998) Peripheral non-small cell lung cancers 2.0 cm or less in diameter: proposed criteria for limited pulmonary resection based upon clinicopathological presentation. Lung Cancer 21:185–191CrossRefPubMed
12.
go back to reference Veeramachaneni NK, Battafarano RJ, Meyers BF et al (2008) Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival. Eur J Cardiothorac Surg 33:466–469CrossRefPubMed Veeramachaneni NK, Battafarano RJ, Meyers BF et al (2008) Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival. Eur J Cardiothorac Surg 33:466–469CrossRefPubMed
13.
go back to reference Farjah F, Lou F, Sima C et al (2013) A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography. J Thorac Oncol 8:1170–1180CrossRefPubMed Farjah F, Lou F, Sima C et al (2013) A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography. J Thorac Oncol 8:1170–1180CrossRefPubMed
14.
go back to reference Deng HY, Wang ZQ, Wang YC et al (2017) Oesophageal adenocarcinoma has a higher risk of lymph node metastasis than squamous cell carcinoma: a propensity score-matched study. Eur J Cardiothorac Surg 52(958–96):2CrossRef Deng HY, Wang ZQ, Wang YC et al (2017) Oesophageal adenocarcinoma has a higher risk of lymph node metastasis than squamous cell carcinoma: a propensity score-matched study. Eur J Cardiothorac Surg 52(958–96):2CrossRef
15.
go back to reference Casal RF, Vial MR, Miller R et al (2017) What exactly is a centrally located lung tumor? Results of an online survey. Ann Am Thorac Soc 14:118–123CrossRefPubMed Casal RF, Vial MR, Miller R et al (2017) What exactly is a centrally located lung tumor? Results of an online survey. Ann Am Thorac Soc 14:118–123CrossRefPubMed
16.
go back to reference Austin PC (2009) Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28:3083–3107CrossRefPubMedPubMedCentral Austin PC (2009) Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28:3083–3107CrossRefPubMedPubMedCentral
17.
go back to reference Pikor LA, Ramnarine VR, Lam S et al (2013) Genetic alterations defining NSCLC subtypes and their therapeutic implications. Lung Cancer 82:179–189CrossRefPubMed Pikor LA, Ramnarine VR, Lam S et al (2013) Genetic alterations defining NSCLC subtypes and their therapeutic implications. Lung Cancer 82:179–189CrossRefPubMed
18.
go back to reference Hou S, Zhou S, Qin Z et al (2017) Evidence, mechanism, and clinical relevance of the transdifferentiation from lung adenocarcinoma to squamous cell carcinoma. Am J Pathol 187:954–962CrossRefPubMed Hou S, Zhou S, Qin Z et al (2017) Evidence, mechanism, and clinical relevance of the transdifferentiation from lung adenocarcinoma to squamous cell carcinoma. Am J Pathol 187:954–962CrossRefPubMed
19.
go back to reference Sigel CS, Moreira AL, Travis WD et al (2011) Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens. J Thorac Oncol 6(1849–185):6 Sigel CS, Moreira AL, Travis WD et al (2011) Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens. J Thorac Oncol 6(1849–185):6
20.
go back to reference Haruki T, Aokage K, Miyoshi T et al (2015) Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection. J Thorac Oncol 10(930–93):6 Haruki T, Aokage K, Miyoshi T et al (2015) Mediastinal nodal involvement in patients with clinical stage I non-small-cell lung cancer: possibility of rational lymph node dissection. J Thorac Oncol 10(930–93):6
21.
go back to reference Wu N, Lv C, Yan S et al (2008) Systemic mediastinal lymph node dissection of right lung cancer: surgical quality control and analysis of mediastinal lymph node metastatic patterns. Interact Cardiovasc Thorac Surg 7(240–24):3 Wu N, Lv C, Yan S et al (2008) Systemic mediastinal lymph node dissection of right lung cancer: surgical quality control and analysis of mediastinal lymph node metastatic patterns. Interact Cardiovasc Thorac Surg 7(240–24):3
22.
go back to reference Koike T, Koike T, Yamato Y et al (2012) Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients. J Thorac Oncol 7(1246–125):1 Koike T, Koike T, Yamato Y et al (2012) Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients. J Thorac Oncol 7(1246–125):1
23.
go back to reference Watanabe S, Oda M, Go T et al (2001) Should mediastinal nodal dissection be routinely undertaken in patients with peripheral small-sized (2 cm or less) lung cancer? Retrospective analysis of 225 patients. Eur J Cardiothorac Surg 20:1007–1011CrossRefPubMed Watanabe S, Oda M, Go T et al (2001) Should mediastinal nodal dissection be routinely undertaken in patients with peripheral small-sized (2 cm or less) lung cancer? Retrospective analysis of 225 patients. Eur J Cardiothorac Surg 20:1007–1011CrossRefPubMed
24.
go back to reference Ohta Y, Oda M, Wu J et al (2001) Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis. J Thorac Cardiovasc Surg 122:900–906CrossRefPubMed Ohta Y, Oda M, Wu J et al (2001) Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis. J Thorac Cardiovasc Surg 122:900–906CrossRefPubMed
25.
go back to reference Lee PC, Port JL, Korst RJ et al (2007) Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg 84(177–18):1 Lee PC, Port JL, Korst RJ et al (2007) Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer. Ann Thorac Surg 84(177–18):1
26.
go back to reference Kanzaki R, Higashiyama M, Fujiwara A et al (2011) Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: risk factors, pattern, and histopathological study. Lung Cancer 71:333–337CrossRefPubMed Kanzaki R, Higashiyama M, Fujiwara A et al (2011) Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: risk factors, pattern, and histopathological study. Lung Cancer 71:333–337CrossRefPubMed
27.
go back to reference Hung JJ, Jeng WJ, Hsu WH et al (2012) Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer. J Thorac Oncol 7:1115–1123CrossRefPubMed Hung JJ, Jeng WJ, Hsu WH et al (2012) Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer. J Thorac Oncol 7:1115–1123CrossRefPubMed
28.
go back to reference Mujoomdar A, Austin JH, Malhotra R et al (2007) Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. Radiology 242:882–888CrossRefPubMed Mujoomdar A, Austin JH, Malhotra R et al (2007) Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. Radiology 242:882–888CrossRefPubMed
29.
go back to reference Gupta P, Sharma PK, Mir H et al (2014) CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis. Oncotarget 5:10170–10179PubMedPubMedCentral Gupta P, Sharma PK, Mir H et al (2014) CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis. Oncotarget 5:10170–10179PubMedPubMedCentral
30.
go back to reference Steuer CE, Behera M, Berry L et al (2016) Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: results from the Lung Cancer Mutation Consortium. Cancer 122(766–77):2 Steuer CE, Behera M, Berry L et al (2016) Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: results from the Lung Cancer Mutation Consortium. Cancer 122(766–77):2
Metadata
Title
Lung Adenocarcinoma has a Higher Risk of Lymph Node Metastasis than Squamous Cell Carcinoma: A Propensity Score-Matched Analysis
Authors
Han-Yu Deng
Miao Zeng
Gang Li
Guha Alai
Jun Luo
Lun-Xu Liu
Qinghua Zhou
Yi-Dan Lin
Publication date
01-03-2019
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 3/2019
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-018-4848-7

Other articles of this Issue 3/2019

World Journal of Surgery 3/2019 Go to the issue

Original Scientific Report (including Papers Presented at Surgical Conferences)

Enterothorax After Hepatic Surgery: A Single-Center Experience